okredo logo
none title certification

UAB "Contract Pharma Solutions" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
2,790,429
84,227
441,057
374,176
11,294
0.20
0.50
60.57
13.41
1,148,727
570,896
799,353
920,270
2022
2,174,272
59,423
2,346
1,445
39
0.22
0.31
60.21
0.07
1,150,170
355,870
768,228
737,812
2023
3,707,376
95,947
748,363
639,955
16,562
0.31
0.39
68.16
17.26
1,790,125
697,597
678,926
1,808,596
unlock data icon

Register and

explore Okredo data
2023
3,707,376
95,947
748,363
639,955
16,562
0.31
0.39
68.16
17.26
1,790,125
697,597
678,926
1,808,596
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

3,707,376 €Ascended71 % *

Sales per employee (€)

95,947 €Ascended61 % *

Profit before tax (€)

748,363 €Ascended31,800 % *

Net Profit (€)

639,955 €Ascended44,188 % *

Profit per employee (€)

16,562 €Ascended42,367 % *

Working capital requirement

0.31 Ascended40.91 % *

Debt-to-equity ratio

0.39 Ascended25.81 % *

Total profitability (%)

68.16 %Ascended13.20 % *

Net profitability (%)

17.26 %Ascended24,557.14 % *

Equity (€)

1,790,125 €Ascended56 % *

Amounts Payable And Liabilities (€)

697,597 €Ascended96 % *

Non-current Assets (€)

678,926 €Descended-12 % *

CurrentAssets (€)

1,808,596 €Ascended145 % *

*over the last year starting selected period